Article R5142-39
For each establishment belonging to companies mentioned in 4° to 10° of Article R. 5142-1, the number of assistant pharmacists or veterinarians is set as follows, depending on the number of staff calc…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 7511–7520 of 29557 articles for “Art. 5 janv. 1983 + Cass. 3e civ.”
For each establishment belonging to companies mentioned in 4° to 10° of Article R. 5142-1, the number of assistant pharmacists or veterinarians is set as follows, depending on the number of staff calc…
For the purposes of calculating the number of staff referred to in articles R. 5142-38 and R. 5142-39, account is taken of persons engaged in the following operations: 1° Manufacturing and import oper…
When a pharmacist or assistant veterinarian recruited in application of article R. 5142-37 is absent or replaces the pharmacist or veterinarian in charge for a period of more than one month, he is rep…
…s must have at least six months' professional experience under the conditions set out in article R. 5142-16 before taking on this role.
For Class IIa devices, the authorized body must, as part of the assessment of the quality system, assess the technical documentation for at least one representative sample of each device subcategory i…
…this device to be understood and its conformity with the essential requirements defined in section 5 of this chapter to be assessed. For the purposes of assessing such conformity, the authorized body…
…ned assessment. In addition, for a device included in list A of the order referred to in article R. 5221-6, the manufacturer submits an application for examination of the design of this device to the…
When providing systemic cancer treatment by immunotherapy or innovative therapeutic medicinal products, the holder of the authorisation for systemic cancer treatment has a patient care organisation wh…
…e management of foreseeable aplasia lasting more than eight days induced by intensive chemotherapy; 5° Patient follow-up during treatment and after the episode of systemic cancer drug treatment. II-Pe…
I. - Establishments authorised for systemic medicinal treatments for cancer with designation B or C must have on site : 1° The organisation of a medical permanence at least by means of operational on-…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More